RENEB Inter-Laboratory Comparison 2021: The FISH-Based Translocation Assay.


Journal

Radiation research
ISSN: 1938-5404
Titre abrégé: Radiat Res
Pays: United States
ID NLM: 0401245

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 28 11 2022
accepted: 07 03 2023
medline: 15 6 2023
pubmed: 15 4 2023
entrez: 14 4 2023
Statut: ppublish

Résumé

Translocation analysis using fluorescence in situ hybridization (FISH) is the method of choice for dose assessment in case of chronic or past exposures to ionizing radiation. Although it is a widespread technique, unlike dicentrics, the number of FISH-based inter-laboratory comparisons is small. For this reason, although the current Running the European Network of Biological and Physical retrospective Dosimetry (RENEB) inter-laboratory comparison 2021 was designed as a fast response to a real emergency scenario, it was considered a good opportunity to perform an inter-laboratory comparison using the FISH technique to gain further experience. The Bundeswehr Institute of Radiobiology provided peripheral blood samples from one healthy human volunteer. Three test samples were irradiated with blinded doses of 0, 1.2, and 3.5 Gy, respectively. Samples were then sent to the seven participating laboratories. The FISH technique was applied according to the standard procedure of each laboratory. Both, the frequency of translocations and the estimated dose for each sample were sent to the coordinator using a special scoring sheet for FISH. All participants sent their results in due time. However, although it was initially requested to send the results based on the full analysis, evaluating 500 equivalent cells, most laboratories only sent the results based on triage, with a smaller number of analyzed cells. In the triage analysis, there was great heterogeneity in the number of equivalent cells scored. On the contrary, for the full analysis, this number was more homogeneous. For all three samples, one laboratory showed outlier yields compared to the other laboratories. Excluding these results, in the triage analysis, the frequency of translocations in sample no. 1 ranged from 0 to 0.013 translocations per cell, and for samples no. 2 and no. 3 the genomic mean frequency were 0.27 ± 0.03 and 1.47 ± 0.14, with a coefficient of variation of 0.29 and 0.23 respectively. Considering only results obtained in the triage analysis for sample no. 1, all laboratories, except one, classified this sample as the non-irradiated one. For sample no. 2, excluding the outlier value, the mean reported dose was 1.74 ± 0.16 Gy indicating a mean deviation of about 0.5 Gy to the delivered dose of 1.2 Gy. For sample no. 3 the mean dose estimated was 4.21 ± 0.21 Gy indicating a mean deviation of about 0.7 Gy to the delivered dose of 3.5 Gy. In the frame of RENEB, this is the second FISH-based inter-laboratory comparison. The whole exercise was planned as a response to an emergency, therefore, a triage analysis was requested for all the biomarkers except for FISH. Although a full analysis was initially requested for FISH, most of the laboratories reported only a triage-based result. The main reason is that it was not clearly stated what was required before starting the exercise. Results show that most of the laboratories successfully discriminated unexposed and irradiated samples from each other without any overlap. A good agreement in the observed frequencies of translocations was observed but there was a tendency to overestimate the delivered doses. Efforts to improve the harmonization of this technique and subsequent exercises to elucidate the reason for this trend should be promoted.

Identifiants

pubmed: 37057978
pii: 492245
doi: 10.1667/RADE-22-00203.1
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

583-590

Informations de copyright

©2023 by Radiation Research Society. All rights of reproduction in any form reserved.

Auteurs

J-F Barquinero (JF)

Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

Y Abe (Y)

Department of Radiation Biology and Protection, Atomic Bomb Disease Institute, Nagasaki University (ABDI), Nagasaki, Japan.

N Aneva (N)

National Centre of Radiobiology and Radiation Protection (NCRRP), Sofia, Bulgaria.

D Endesfelder (D)

Bundesamt für Strahlenschutz (BfS), Oberschleissheim, Germany.

D Georgieva (D)

National Centre of Radiobiology and Radiation Protection (NCRRP), Sofia, Bulgaria.

Vst Goh (V)

Singapore Nuclear Research and Safety Initiative (SNRSI), Singapore.

E Gregoire (E)

Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay aux Roses, France.

R Hristova (R)

National Centre of Radiobiology and Radiation Protection (NCRRP), Sofia, Bulgaria.

Y Lee (Y)

Korea Institute of Radiological & Medical Sciences, Laboratory of Biological Dosimetry (KIRAMS), Seoul, Korea.

J-S Martínez (JS)

Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay aux Roses, France.

P-K Meher (PK)

Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University (SU), Stockholm, Sweden.

T Miura (T)

Department of Risk Analysis and Biodosimetry, Institute of Radiation Emergency Medicine, Hirosaki University (IREM), Aomori, Japan.

M Port (M)

Bundeswehr Institute of Radiobiology affiliated to the University of Ulm (BIR), Munich, Germany.

M Pujol-Canadell (M)

Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

M J Prieto-Rodriguez (MJ)

Hospital General Universitario Gregorio Marañón, Laboratorio de dosimetría biológica (SERMAS), Madrid, Spain.

K-M Seong (KM)

Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay aux Roses, France.

Y Suto (Y)

Biodosimetry Group, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.

K Takebayashi (K)

Department of Risk Analysis and Biodosimetry, Institute of Radiation Emergency Medicine, Hirosaki University (IREM), Aomori, Japan.

N Tsuyama (N)

Department of Radiation Life Sciences, Fukushima Medical University (FMU), Fukushima, Japan.

A Wojcik (A)

Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University (SU), Stockholm, Sweden.

H-J Yoon (HJ)

Korea Institute of Radiological & Medical Sciences, Laboratory of Biological Dosimetry (KIRAMS), Seoul, Korea.

M Abend (M)

Bundeswehr Institute of Radiobiology affiliated to the University of Ulm (BIR), Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH